Selected research
Market Structure
Global Eszopiclone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Eszopiclone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Eszopiclone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Eszopiclone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Eszopiclone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Eszopiclone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Eszopiclone include Tasly Pharmaceutical, Sun Pharmaceutical, Kanghong Pharmaceutical, Wockhardt, Tapi Teva, Shanghai Pharmaceuticals Holding, Kanghong Pharmaceutical, Glenmark Life Sciences and Dr. Reddy’s Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Eszopiclone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Eszopiclone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Eszopiclone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Eszopiclone market size, projected growth trends, production technologies, key applications, and end-use industries.
Eszopiclone Segment by Company
Tasly Pharmaceutical
Sun Pharmaceutical
Kanghong Pharmaceutical
Wockhardt
Tapi Teva
Shanghai Pharmaceuticals Holding
Kanghong Pharmaceutical
Glenmark Life Sciences
Dr. Reddy’s Laboratories
Centaur Pharmaceuticals
Admiron Life
Eszopiclone Segment by Type
Purity Above 98%
Purity Below 98%
Eszopiclone Segment by Application
Tablet
Capsule
Other
Eszopiclone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eszopiclone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Eszopiclone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eszopiclone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Eszopiclone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Eszopiclone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Eszopiclone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Eszopiclone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Purity Above 98%
- Purity Below 98%
Applications
- Tablet
- Capsule
- Other
Companies covered
- Tasly Pharmaceutical
- Sun Pharmaceutical
- Kanghong Pharmaceutical
- Wockhardt
- Tapi Teva
- Shanghai Pharmaceuticals Holding
- Kanghong Pharmaceutical
- Glenmark Life Sciences
- Dr. Reddy’s Laboratories
- Centaur Pharmaceuticals
- Admiron Life
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Eszopiclone Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Eszopiclone Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Eszopiclone Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Eszopiclone Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Eszopiclone Market Dynamics
- 2.1 Eszopiclone Industry Trends
- 2.2 Eszopiclone Industry Drivers
- 2.3 Eszopiclone Industry Opportunities and Challenges
- 2.4 Eszopiclone Industry Restraints
3 Eszopiclone Market by Manufacturers
- 3.1 Global Eszopiclone Revenue by Manufacturers (2021-2026)
- 3.2 Global Eszopiclone Sales by Manufacturers (2021-2026)
- 3.3 Global Eszopiclone Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Eszopiclone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Eszopiclone Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Eszopiclone Manufacturers, Product Type & Application
- 3.7 Global Eszopiclone Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Eszopiclone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Eszopiclone Players Market Share by Revenue in 2025
- 3.8.3 2025 Eszopiclone Tier 1, Tier 2, and Tier 3
4 Eszopiclone Market by Type
- 4.1 Eszopiclone Type Introduction
- 4.1.1 Purity Above 98%
- 4.1.2 Purity Below 98%
- 4.2 Global Eszopiclone Sales by Type
- 4.2.1 Global Eszopiclone Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Eszopiclone Sales by Type (2021-2032)
- 4.2.3 Global Eszopiclone Sales Market Share by Type (2021-2032)
- 4.3 Global Eszopiclone Revenue by Type
- 4.3.1 Global Eszopiclone Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Eszopiclone Revenue by Type (2021-2032)
- 4.3.3 Global Eszopiclone Revenue Market Share by Type (2021-2032)
5 Eszopiclone Market by Application
- 5.1 Eszopiclone Application Introduction
- 5.1.1 Tablet
- 5.1.2 Capsule
- 5.1.3 Other
- 5.2 Global Eszopiclone Sales by Application
- 5.2.1 Global Eszopiclone Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Eszopiclone Sales by Application (2021-2032)
- 5.2.3 Global Eszopiclone Sales Market Share by Application (2021-2032)
- 5.3 Global Eszopiclone Revenue by Application
- 5.3.1 Global Eszopiclone Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Eszopiclone Revenue by Application (2021-2032)
- 5.3.3 Global Eszopiclone Revenue Market Share by Application (2021-2032)
6 Global Eszopiclone Sales by Region
- 6.1 Global Eszopiclone Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Eszopiclone Sales by Region (2021-2032)
- 6.2.1 Global Eszopiclone Sales by Region (2021-2026)
- 6.2.2 Global Eszopiclone Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Eszopiclone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Eszopiclone Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Eszopiclone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Eszopiclone Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Eszopiclone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Eszopiclone Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Eszopiclone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Eszopiclone Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Eszopiclone Revenue by Region
- 7.1 Global Eszopiclone Revenue by Region
- 7.1.1 Global Eszopiclone Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Eszopiclone Revenue by Region (2021-2026)
- 7.1.3 Global Eszopiclone Revenue by Region (2027-2032)
- 7.1.4 Global Eszopiclone Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Eszopiclone Revenue (2021-2032)
- 7.2.2 North America Eszopiclone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Eszopiclone Revenue (2021-2032)
- 7.3.2 Europe Eszopiclone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Eszopiclone Revenue (2021-2032)
- 7.4.2 Asia-Pacific Eszopiclone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Eszopiclone Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Eszopiclone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Tasly Pharmaceutical
- 8.1.1 Tasly Pharmaceutical Company Information
- 8.1.2 Tasly Pharmaceutical Business Overview
- 8.1.3 Tasly Pharmaceutical Eszopiclone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Tasly Pharmaceutical Eszopiclone Product Portfolio
- 8.1.5 Tasly Pharmaceutical Recent Developments
- 8.2 Sun Pharmaceutical
- 8.2.1 Sun Pharmaceutical Company Information
- 8.2.2 Sun Pharmaceutical Business Overview
- 8.2.3 Sun Pharmaceutical Eszopiclone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sun Pharmaceutical Eszopiclone Product Portfolio
- 8.2.5 Sun Pharmaceutical Recent Developments
- 8.3 Kanghong Pharmaceutical
- 8.3.1 Kanghong Pharmaceutical Company Information
- 8.3.2 Kanghong Pharmaceutical Business Overview
- 8.3.3 Kanghong Pharmaceutical Eszopiclone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Kanghong Pharmaceutical Eszopiclone Product Portfolio
- 8.3.5 Kanghong Pharmaceutical Recent Developments
- 8.4 Wockhardt
- 8.4.1 Wockhardt Company Information
- 8.4.2 Wockhardt Business Overview
- 8.4.3 Wockhardt Eszopiclone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Wockhardt Eszopiclone Product Portfolio
- 8.4.5 Wockhardt Recent Developments
- 8.5 Tapi Teva
- 8.5.1 Tapi Teva Company Information
- 8.5.2 Tapi Teva Business Overview
- 8.5.3 Tapi Teva Eszopiclone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Tapi Teva Eszopiclone Product Portfolio
- 8.5.5 Tapi Teva Recent Developments
- 8.6 Shanghai Pharmaceuticals Holding
- 8.6.1 Shanghai Pharmaceuticals Holding Company Information
- 8.6.2 Shanghai Pharmaceuticals Holding Business Overview
- 8.6.3 Shanghai Pharmaceuticals Holding Eszopiclone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Shanghai Pharmaceuticals Holding Eszopiclone Product Portfolio
- 8.6.5 Shanghai Pharmaceuticals Holding Recent Developments
- 8.7 Kanghong Pharmaceutical
- 8.7.1 Kanghong Pharmaceutical Company Information
- 8.7.2 Kanghong Pharmaceutical Business Overview
- 8.7.3 Kanghong Pharmaceutical Eszopiclone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Kanghong Pharmaceutical Eszopiclone Product Portfolio
- 8.7.5 Kanghong Pharmaceutical Recent Developments
- 8.8 Glenmark Life Sciences
- 8.8.1 Glenmark Life Sciences Company Information
- 8.8.2 Glenmark Life Sciences Business Overview
- 8.8.3 Glenmark Life Sciences Eszopiclone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Glenmark Life Sciences Eszopiclone Product Portfolio
- 8.8.5 Glenmark Life Sciences Recent Developments
- 8.9 Dr. Reddy’s Laboratories
- 8.9.1 Dr. Reddy’s Laboratories Company Information
- 8.9.2 Dr. Reddy’s Laboratories Business Overview
- 8.9.3 Dr. Reddy’s Laboratories Eszopiclone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Dr. Reddy’s Laboratories Eszopiclone Product Portfolio
- 8.9.5 Dr. Reddy’s Laboratories Recent Developments
- 8.10 Centaur Pharmaceuticals
- 8.10.1 Centaur Pharmaceuticals Company Information
- 8.10.2 Centaur Pharmaceuticals Business Overview
- 8.10.3 Centaur Pharmaceuticals Eszopiclone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Centaur Pharmaceuticals Eszopiclone Product Portfolio
- 8.10.5 Centaur Pharmaceuticals Recent Developments
- 8.11 Admiron Life
- 8.11.1 Admiron Life Company Information
- 8.11.2 Admiron Life Business Overview
- 8.11.3 Admiron Life Eszopiclone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Admiron Life Eszopiclone Product Portfolio
- 8.11.5 Admiron Life Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Eszopiclone Value Chain Analysis
- 9.1.1 Eszopiclone Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Eszopiclone Production Mode & Process
- 9.2 Eszopiclone Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Eszopiclone Distributors
- 9.2.3 Eszopiclone Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst